LECAP Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,217
Closed -$1.61M – 370
2026
Q2
$1.61M Buy
3,217
+1,151
+56% +$553K 0.69% 36
2026
Q1
$1.02M Buy
+2,066
New +$1.12M 0.38% 111
2025
Q2
– Sell
-3,091
Closed -$1.54M – 391
2025
Q1
$1.54M Sell
3,091
-1,317
-30% -$713K 0.36% 125
2024
Q4
$2.29M Sell
4,408
-358
-8% -$197K 0.62% 41
2024
Q3
$2.95M Sell
4,766
-3,347
-41% -$1.98M 0.64% 44
2024
Q2
$4.49M Buy
+8,113
New +$4.65M 0.97% 6

Other funds holding TMO

LECAP Asset Management's TMO Position: Q3 2026 in Review

LECAP Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2026, closing a stake of 3,217 shares — an estimated $1.61M sold.

LECAP Asset Management first reported a position in TMO in Q2 2024 and held it in 6 quarters. The position peaked at $4.49M in Q2 2024. 2,801 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • LECAP Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2026 after selling out during the quarter.
  • LECAP Asset Management sold 3,217 Thermo Fisher Scientific shares in Q3 2026, an estimated $1.61M.
  • LECAP Asset Management first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 6 quarters.
  • LECAP Asset Management's Thermo Fisher Scientific position peaked at $4.49M in Q2 2024.
  • 2,801 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on LECAP Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.